Planta Med 2006; 72(2): 175-179
DOI: 10.1055/s-2005-916181
Original Paper
Natural Product Chemistry
© Georg Thieme Verlag KG Stuttgart · New York

Eremophilane Sesquiterpenes from Ligularia myriocephala

Jun-Xi Liu1 , Xiao-Ning Wei1 , Yan-Ping Shi1 , 2
  • 1Key Laboratory for Natural Medicine of the Gansu Province, Lanzhou Institute of Chemical Physics, Graduate School of the Chinese Academy of Sciences, Chinese Academy of Sciences, Lanzhou, P. R. China
  • 2State Key Laboratory of Applied Organic Chemistry, Lanzhou University, Lanzhou, P. R. China
Further Information

Prof. Yan-Ping Shi

Lanzhou Institute of Chemical Physics

Chinese Academy of Sciences

Lanzhou 730000

People’s Republic of China

Fax: +86-931-827-7088

Email: shiyp@lzb.ac.cn

Publication History

Received: May 7, 2005

Accepted: July 13, 2005

Publication Date:
05 December 2005 (online)

Table of Contents #

Abstract

Five new eremophilenolides, 1β-angeloyloxy-6β,10β-dihydroxy-8β-methoxyeremophil-7(11)-en-8α,12-olide (1), 1β-angeloyloxy-6β,10α-dihydroxy-8α-methoxyeremophil-7(11)-en-8β,12-olide (2), 1β,6β-diangeloyloxy-8β,10β-dihydroxyeremophil-(11)-en-8α,12-olide (3), 1β,6β-diangeloyloxy-8α,10 α-dihydroxyeremophil-7(11)-en-8β,12-olide (4), 1β-angeloyloxy-8-oxoeremophil-6,9-dien-12-oic acid methyl ester (5) and one known compound, 8β,10β-dihydroxyeremophilenolide (6) were isolated from the extract of the whole plant of Ligularia myriocephala Ling. Their structures and stereochemistry were elucidated by various spectroscopic methods including intensive 2D-NMR techniques (COSY, gHMQC, gHMBC and 1H-1H NOESY) and HR-ESI-MS. A single-crystal X-ray experiment was performed for compound 1.

#

Introduction

Members of the genus Ligularia (Compositae) have been used for a long time to cure pulmonary tuberculosis, hemoptysis, urinary tract blockages, rheumatism, common cold, pharyngitis, laryngitis, hepatitis, bronchitis and asthma. For possible pharmaceutical uses, Ligularia species have been studied by our group for several years [1], [2], and have been found to be an important source of sesquiterpenes of the eremophilane type [3], [4], [5], [6], [7]. Ligularia myriocephala is limited to Teibei, northwestern China and has been used as a folk medicine to reduce phlegm, relieve cough, cure pellagra and rheumatic edema [8]. In the course of our investigations on natural sesquiterpenes, we selected L. myriocephala, whose chemical constituents have not been reported previously. One known eremophilenolide and five novel eremophilane sesquiterpenes have been isolated from this species.

#

Materials and Methods

#

General

Melting points were obtained on an X-4 digital display micro-melting point apparatus, and are uncorrected. Optical rotations were taken on a polarimeter 341 (Perkin Elmer) in CHCl3 solution. UV spectra were observed on a Shimadzu UV-240 spectrophotometer in MeOH solution. IR spectra were measured on a Nicolet NEXUS 670 FT-IR spectrometer. 1H-NMR (400.16 Hz), 13C-NMR (100.32 Hz) and 2D-NMR were recorded on a Varian INOVA 400 MHz FT-NMR spectrometer with TMS as internal standard. HR-ESI-MS was recorded on a Bruker APEX II. Silica gel (200 - 300 mesh) was used for CC and silica GF254 (10 - 40 μ) for TLC. Spots were detected on TLC under UV light or by heating after spraying with 98 % H2SO4:EtOH = 5 : 95 (v:v).

#

Plant material

The whole plant of L. myriocephala was collected in August 2001 in Ling Zhi County, Teibei, P. R. China, and was identified by Prof. Guo-Liang Zhang, Department of Biology, Lanzhou University, Lanzhou, P. R. China. A voucher specimen (No. 2001 - 20) has been deposited in our Key Laboratory for Natural Medicine of Gansu Province.

#

Extraction and isolation

The dried whole plant of L. myriocephala (4.4 kg) was powdered and extracted at room temperature with petroleum ether (60 - 90 °C)-Et2O-MeOH (v:v:v, 1 : 1:1) (10 L each time, 4 × 7 days). The solvent was removed under reduced pressure to give a residue (110.0 g), which was subjected to column chromatography (CC) over silica gel (200 - 300 mesh, 2000 g), eluting with a gradient of petroleum ether (60 - 90 °C)-acetone (v:v, 50 : 1, 40 : 1, 30 : 1, 10 : 1, 5 : 1, 3 : 1 and 1 : 1; 500 mL for each eluent) and finally with MeOH (2000 mL). Based on differences in composition indicated by TLC, 8 crude fractions [F1 (v:v 50 : 1, 10.0 g), F2 (v:v 40 : 1, 5.0 g), F3 (v:v 30 : 1, 4.0 g), F4 (v:v 10 : 1, 15.0 g), F5 (v:v 5 : 1, 10.0 g), F6 (v:v 3 : 1, 8.0 g), F7 (v:v 1 : 1, 5.0 g), and F8 (MeOH, 15.0 g)] were obtained. F2 was separated by CC over silica gel (200 - 300 mesh, 100 g) with petroleum ether (60 - 90 °C)-EtOAc (v:v, 20 : 1, 1000 mL) to give 1 (35 mg). The mother liquid was separated by repeated preparative TLC (silica GF254, 10 - 40 μ) with petroleum ether (60 - 90 °C)-CHCl3-EtOAc (v:v:v, 10 : 1:1, 3 × 50 mL, three times, Rf = 0.15) to afford an inseparable mixture of 3 and 4 (11 mg) which could not be separated further by CC and RP-HPLC. F3 was subjected to CC on silica gel (80 g) with a gradient of petroleum ether (60 - 90 °C)-EtOAc (v:v, 10 : 1, 1000 mL, 8 : 1, 900 mL, 5 : 1, 700 mL) as eluent. The eluate (v:v, 8 : 1) was purified by petroleum ether (60 - 90 °C)-acetone (v:v, 5 : 1, 800 mL) to give 2 (10 mg). F4 was purified by CC on silica gel (40 g) and eluted repeatedly with petroleum ether (60 - 90 °C)-acetone (v:v, 6 : 1, 200 mL) to give crude 5 (6 mg) and 6 (11 mg). Crude 5 was further purified by preparative TLC with petroleum ether (60 - 90 °C)-acetone (v:v, 3 : 1, Rf = 0.45) to yield pure 5 (5 mg).

1β-Angeloyloxy-6β,10β-dihydroxy-8β-methoxyeremophil-7(11)-en-8α,12-olide (1): Colorless needles, C21H30O7, m. p. 180 - 181 °C; [α]D 20: + 186° (c 0.70, CHCl3); IR (KBr): ν = 3474.1, 2948.9, 1776.0, 1704.4, 1644.9, 1459.0, 1230.9 cm-1; UV (MeOH): λmax (log ε) = 220 nm (5.7); HR-ESI-MS: m/z = 417.1869 [M + Na]+ (calcd. for C21H30O7Na: 417.1884); 1H-NMR and 13C-NMR, see Table [1].

1β-Angeloyloxy-6β,10α-dihydroxy-8α-methoxyeremophil-7(11)-en-8β,12-olide (2): Colorless needles, C21H30O7, m. p. 170 - 171 °C; [α]D 20: -11° (c 1.12, CHCl3); IR (KBr): ν = 3462.2, 2918.8, 1739.4, 1679.3, 1646.3, 1460.7, 1278.6 cm-1; UV (MeOH): λmax (log ε) = 220 nm (4.3); HR-ESI-MS: m/z = 395.2065 [M + H]+ (calcd. for C21H31O7 : 395.2064); 1H-NMR and 13C-NMR, see Tables [2] and [3].

1β,6β-Diangeloyloxy-8β,10β-dihydroxyeremophil-7(11)-en-8α,12-olide (3) and 1β,6β-diangeloyloxy-8α,10α-dihydroxyeremophil-7(11)-en-8β,12-olide (4): Colorless gum, C25H34O8; HR-ESI-MS: m/z = 480.2590 [M + NH4]+ (calcd. for C25H38O8N: 480.2592); 1H-NMR and 13C-NMR, see Tables [2] and [3].

1β-Angeloyloxy-8-oxoeremophil-6,9-dien-12-oic acid methyl ester (5): Colorless gum, C21H28O5; HR-ESI-MS: m/z = 361.2015 [M + H]+ (calcd. for C21H29O5 : 361.2010); 1H-NMR and 13C-NMR, see Tables [2] and [3].

8β,10β-Dihydroxyeremophilenolide (6): Colorless gum, C15H22O4; 1H-NMR and 13C-NMR, see Tables [2] and [3].

Zoom Image

Fig. 1 Structures of compounds 1 - 6.

Table 1 1H-NMR (400.16 MHz), 13C-NMR (100.32 MHz) spectral data and gHMBC correlations of compound 1 (In CDCl3, δ ppm, TMS); coupling constants (Hz) are in parentheses*
H δH C δC HMBC correlations
1 4.85 t (2.8) 1 75.5 H-3α, 3β, H-9α, 9β
1.76 m 2 27.1
1.72 m
1.57 m 3 25.7 H-1, H-15
1.37 m
4 1.265 m 4 33.4 H-14, H-15
5 47.4 H-1, H-6, H-9β, H-14, H-15
6 4.51 s 6 72.2 H-14, H-13
7 153.7 H-9β, H-13
8 105.4 H-6, H-9α, H-9β, 8-OCH3, H-13
2.25 d (14.8) 9 43.74 H-1
2.43 d (14.8)
10 76.15 H-1, H-6, H-9α, H-9β, H-14
11 124.4 H-13
12 170.6 H-13
13 1.91 s 13 8.9
14 1.33 s 14 12.7
15 0.86 d (6.7) 15 16.1
1′ 167.7 H-1, H-5′
2′ 127.3 H-4′, H-5′
3′ 6.09 q (7.2, 1.2) 3′ 139.6 H-4′, H-5′
4′ 1.92 m 4′ 20.7
5′ 1.98 dq (7.2, 1.2) 5′ 15.8
OCH3 3.25 s OCH3 51.1
* Assignments of chemical shifts of 1 was confirmed by DEPT, gHMQC, gHMBC and 1H-1H NOESY experiments.
Table 2 1H-NMR spectral data of compounds 2, 3, 4, 5 and 6 (400.16 MHz, in CDCl3, δ ppm, TMS ); coupling constants (Hz) are in parentheses
H 2a 3b 4c 5d, e 6
1 5.29 dd (9.2, 4.8) 4.97, s 5.64 dd (11.6, 5.2) 5.54 s 1.72 m
1.38 m
1.83 m 1.75 m 1.63 m 2.10m 1.50 m
1.89 m 1.67 m 1.45 2.19m 1.42
1.50m 1.62bm 1.75 m 1.79 m 1.22 m
1.91 m 1.62bm 1.65 m 1.70m 1.38 m
4 2.13 m 1.39 m 1.80 m 1.53 m 1.29 m
6 4.81 d (1.6) 5.80 s 6.14 d (1.6) 6.86 s 2.34 d (16)
2.55 d (16)
2.50 d (14.0) 2.26 d (14.4) 1.87 d (15.2) 6.35 s 2.08 d (14.4, 2.3)
1.75 d (14.0) 2.37 d (14.4) 2.32 d (15.2) H11 3.72 q (7.2) 2.34 d (14.4, 2.3)
13 2.07 d (1.6) 1.99 s 1.80 d (1.6) 1.31 d (7.2) 1.77 d (1.5)
14 0.96 s 1.21 s 1.07 s 1.23 s 1.00 s
15 1.21 d (7.6) 0.96 d (6.4) 1.20 d (8.4) 1.09 d (6.4) 0.81 d (6.4)
a R1-OAng: δH = 6.02 q (7.2, 1.2), 1.94 dt (7.2, 1.6), 1.88 dt (7.2, 1.6); R3 -OCH3:  δH = 3.08, s.
b R1-OAng: δH = 6.11 q (5.6, 1.2), 2.00 m, 1.90 m; R2-OAng: δH = 6.11 q (5.6, 1.2), 1.98 m, 1.86 m.
c R1-OAng: δH = 6.22 q (8.8, 1.2), 1.99 m, 1.92 m; R2-OAng: δH = 6.11 q (5.6, 1.2), 2.02 m, 1.96 m.
d R1-OAng: δH = 6.09 m, 1.98 m, 1.85 m.
e COOCH3: δH = 3.64 s.
Table 3 13C-NMR spectral data of compounds 2, 3, 4, 5 and 6 (100.32 MHz, in CDCl3 , δ ppm, TMS)
C 2a 3b 4c 5d,e 6
1 73.7 75.5 74.6 74.4 34.7
2 21.4 25.5 26.2 32.3 22.0
3 26.3 30.9 26.9 25.7 29.5
4 31.05 33.5 31.4 41.1 33.4
5 50.8 47.1 50.0 43.4 46.1
6 70.4 70.8 70.4 151.7 30.9
7 156.5 151.5 155.0 136.6 158.7
8 103.9 101.8 100.6 184.8 102.6
9 41.3 44.0 42.6 127.3 42.8
10 75.0 75.1 75.0 160.3 74.5
11 127.5 128.5 124.5 37.9 122.5
12 171.6 170.6 171.3 174.9 172.0
13 8.9 8.7 8.0 16.4 8.3
14 12.5 12.7 14.1 18.0 14.8
15 16.8 16.5 16.6 16.1 16.2
a R1-OAng: δc = 166.5, 127.8, 138.1, 20.6, 15.8; R3 -OCH3: δC = 50.1.
b R1-OAng: δc = 167.8, 127.2, 139.9, 20.7, 15.8; R2-OAng: δC = 166.6, 127.0, 141.0, 20.8, 16.1.
c R1-OAng: δc = 168.2, 126.7, 141.8, 20.6, 15.8; R2-OAng: δC = 166.0, 126.3, 140.9, 20.6, 16.0.
d R1-OAng: δC = 166.6, 128.2, 139.3, 20.7, 15.8.
e CO-OCH3: δC = 52.0.
#

X-ray crystal data and structure refinement of 1

Crystal data: C21H30O7, Formula wt.: 394.46, D cal = 1.282 g/cm3. Single-crystal X-ray diffraction data were collected by using a MAC Science DIP 2030k image plate with graphite monochrome MoKa radiation. The crystal (0.10 × 0.20 × 1.00 mm) belongs to the monoclinic system, space group P21. Accurate cell parameters are a = 11.044(1), b = 8.360(1), c = 11.214 2(1) Å,  β  = 99.31(1)°, V = 1021.7 (2) Å3, Z = 2, There were 2200 reflections, of which 2054 (|F| 2 ≥ 3δ|F|2) were observed. The position of 28 non-hydrogen atoms was obtained directly from an E-map. The structure was solved by direct methods using SHELXS-86 for the refinement. Positions of the other non-hydrogen atoms and the type of atoms was determined by using least-squares calculations and difference Fourier methods in turn. Geometric calculations and difference Fourier methods proved the positions of all hydrogen atoms. The structure was finally refined to Rf = 0.054 and R w = 0.053.

#

Results and Discussion

Compound 1 was obtained as colorless needles, m. p.180 - 181 °C, [α]D 20: + 186° (c 0.70, CHCl3), the HR-ESI-MS showed m/z = 417.1884 [M + Na]+ (calcd. for C21H30O7Na: 417.1889). The IR (KBr) spectrum showed bands for a hydroxy group (3474.0 and 3435.4 cm-1) and an α,β-unsaturated-γ-lactone (1644.9, 1704.4 and 1776.0 cm-1), UV λmax = 220 nm. Except for the typical carbon signals of an angeloyl group (Table [1]) and a methoxy group (δC = 51.1, δH = 3.25, 3H, s), the 13C-NMR spectrum (Table [1]) showed 15 carbons including three methyls, three methylenes, three methines, and six quaternary carbons, assigned by a DEPT experiment, which revealed that 1 was as a sesquiterpenoid. By comparison of its spectral data with those of known sesquiterpene lactones [9], [10], [11], 1 was an eremophilanoide with an angeloyl, a methoxy and two hydroxy groups. The location of the angeloyloxy moiety was established by the gHMBC correlation of H-1 (δH = 4.85, t, J = 2.8 Hz) with C-1′ (δC = 167.7), C-10 (δC = 76.2), C-9 (δC = 43.7) and C-5 (δC = 47.4). That the methoxy group was attached at C-8 was deduced by the gHMBC correlation of the methoxy protons (-OCH3) with C-8 (δC = 105.4). The hydroxy group attached to C-10 was β-oriented because rings A and B were cis-fused from the chemical shift of the 14-CH3H = 1.33, 3H, s) downfield of 15-CH3 (0.86, 3H, d) [2], [9], [10]. This was supported by a cross-peak between H-4α and H-9α in the NOESY spectrum (Fig. [2]). That the hydroxy group at C-6 was β-oriented was also shown by a cross-peak between H-6α and H-15 (Fig. [2]). The pattern and smaller J values between H-1 and H2 - 2 (J 1e,2e = J 1e,2a = 2.8 Hz) indicated that the angeloyl group at C-1 was β-oriented. The structure and relative stereochemistry were confirmed by X-ray crystallography (Fig. [3]). Hence, 1 was Iβ-angeloyloxy-6β,10β-dihydroxy-8β-methoxyeremophil-7(11)-en-8α, 12-olide.

Compound 2 was obtained colorless needles, m. p. 170 - 171 °C, [α]D 20: -11° (c 1.12, CHCl3), the HR-ESI-MS showed m/z = 395.2065 [M + H]+ (calcd. for C21H31O7 : 395.2064). The IR (KBr) spectrum showed bands for a hydroxy group (3474.0 and 3435.4 cm-1) and an α,β-unsaturated-γ-lactone (1646.3, 1679.3 and 1739.4 cm-1), UV λmax = 220 nm. The 1H- and 13C-NMR spectra were very similar to those of 1 except for the 15-CH3H = 1.21, 3H, d, J = 7.6 Hz) that was downfield of 14-CH3H = 0.96, 3H, s). This suggested that 2 was a trans-eremophilane with an α-OH at C-10 and an α-OCH3 at C-8 [9], [12]. This trans-fusion of rings A and B was supported by three cross-peaks, H-1α with H-9α, H-4α with H-6α and CH3 - 14 with H-9β in the NOESY spectrum. Moreover, a cross-peak between H-6α and OCH3 - 8 in the NOESY spectrum and the homoallylic coupling (J = 1.6 Hz) between H-6α and CH3 - 13 protons also showed the OCH3 at C-8 was α-oriented and the OH group at C-6 was β-oriented [13], [14]. The other structural information of 2 also could be concluded from the gHMBC. Then, 2 was 1β-angeloyloxy-6β, 10α-dihydroxy-8α-methoxy-eremophil-7(11)-en-8β,12-olide.

Compounds 3 and 4 were obtained as a mixture (ratio 2 : 1, by NMR), colorless gum, the HRESI-MS showed m/z = 480.2590 [M+NH4]+ (calcd. 480.2592 for C25H38O8N). The 13C-NMR experiment showed 50 signals for the mixture of two compounds that have the same formula compositions, C25H34O8. Besides the typical carbon signals of four angeloyl groups (Tables [2] and [3]), the remaining thirty carbons (Tables [2] and [3]) were six methyls, six methylenes, six methines, and twelve quaternary carbons, assigned by a DEPT experiment, which revealed that 3 and 4 were sesquiterpenoids, respectively. By comparison of spectral data with those of 1 and 2, compounds 3 and 4 were an eremophilanoid with two angeloyl groups and two hydroxy groups (Tables [2] and [3]).

The locations of the two angeloyl moieties of 3 were established by the gHMBC correlations of H-1 (δH = 4.97, t, J = 2.8 Hz) with the C-1′ (δC = 167.8) and H-6 (δH = 5.80, s) with C-1′′ (δC = 166.6). Compared to 1, the OCH3 - 8 (δC = 101.8) was replaced by an OH group and the missed homoallylic spinning couple between H-6 and H-13 (dH = 1.99, 3H, s) suggested the OH-8 was β-oriented. The hydroxy group attached to C-10 (δC = 75.1) was β-oriented because rings A and B were cis-fused from the chemical shift of the 14-CH3H = 1.21, 3H, s) downfield of 15-CH3H = 0.96, d, J = 6.4 Hz) [13]. This was supported by a cross-peak between H-4α and H-9α in the NOESY spectrum. That angeloyl group at C-6 (δC = 70.8) was β-axial was also showed by a cross-peak between H-6α and H-15. The pattern and smaller J values between H-1 and H2 - 2 (J 1e,2e = J 1e,2a = 2.8 Hz) showed that the angeloyl group at C-1 was β-oriented. Hence, 3 was 1β,6β-diangeloyloxy-8β,10β-dihydroxy eremophil-7(11)-en-8α,12-olide

The locations of the two angeloyloxy moieties of 4 were also established by the gHMBC correlation of H-1 (δH = 5.64, dd, J = 11.6, 5.2 Hz) with the C-1′ (δC = 168.2) and H-6 (δH = 6.14, d, J = 1.6 Hz) with C-1′′ (δC = 166.0). Compared to 3, the 15-CH3H = 1.20, 3H, d, J = 8.4 Hz) was downfield of 14-CH3H = 1.07, 3H, s). This suggested 4 was a trans-eremophilane with the α-OH at C-10 and C-8, respectively [14]. The homoallylic coupling (J = 1.6 Hz) between H-6α and CH3 - 13 protons also showed that OH-8 was α-oriented. The other structural information of 4 could also be concluded from the gHMBC experiment. Then, 4 was 1β,6β-diangeloyloxy-8α,10α-dihydroxyeremophil-7(11)-en-8β,12-olide.

Compound 5 was obtained as a colorless gum, the HR-ESI-MS showed m/z = 361.2015 [M + H]+, calcd. for C21H29O5 : 360.2385). The 1H- and 13C-NMR spectra of 5 showed similarities with the reported compound, 1β-hydroxy-8-oxoeremophil-6,9-dien-12-oic acid methyl ester except for an angeloyl group (δC = 166.6, 128.2, 139.3,  20.7, 15.8; δH = 6.09, 1H, m; 1.85, 3H, m; 1.98, 3H, m) in 5 instead of a hydroxy group in the reported compound, obtained by methoxylation of 1β-hydroxy-8-oxoeremophil-6,9-dien-12-oic acid [15]. The location of the angeloyl moiety was established by the strong gHMBC correlation of H-1 (δH = 5.54 s) with C-1′. The methoxy group at C-12 was established by the gHMBC correlation of the protons of OCH3H = 3.64, 3H, s) with C-12. Thus, 5 was 1β-angeloyloxy-8-oxoeremophil-6, 9-diene-12-oic acid methyl ester. Unfortunately, we could not obtain its spectral data of UV, [α]D and IR because it decomposed in CDCl3.

Compound 6 was obtained as a colorless gum. Its 1H- and 13C-NMR spectra were completely the same as the reported compound 8β,10β-dihydroxyeremophilenolide, which has been isolated from Hertia cheirifolia [9].

Zoom Image

Fig. 2 Key NOESY correlations (H and H) of 1.

Zoom Image

Fig. 3 X-ray crystal structure of 1.

#

Acknowledgements

This work was supported by the National Natural Sciences Foundation of China (NSFC No. 20 021 001, 20 372 029 and 20 475 057).

#

References

Prof. Yan-Ping Shi

Lanzhou Institute of Chemical Physics

Chinese Academy of Sciences

Lanzhou 730000

People’s Republic of China

Fax: +86-931-827-7088

Email: shiyp@lzb.ac.cn

#

References

Prof. Yan-Ping Shi

Lanzhou Institute of Chemical Physics

Chinese Academy of Sciences

Lanzhou 730000

People’s Republic of China

Fax: +86-931-827-7088

Email: shiyp@lzb.ac.cn

Zoom Image

Fig. 1 Structures of compounds 1 - 6.

Zoom Image

Fig. 2 Key NOESY correlations (H and H) of 1.

Zoom Image

Fig. 3 X-ray crystal structure of 1.